Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID)

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• Common variable immunodeficiency (CVID) is characterized by impaired B cell function and low immunoglobulin (Ig) production.
• A heterozygous mutation (C104R) in the transmembrane activator and CAML interactor (TACI) gene is associated with CVID, but the underlying mechanism remains unclear.
• It is unknown whether this mutation causes haploinsufficiency or dominant interference with TACI function.

Purpose of the Study:

• To investigate the mechanism by which the TACI C104R mutation contributes to CVID.
• To determine if the TACI C104R mutation interferes with normal TACI signaling pathways.
• To elucidate the role of TACI preassembly in ligand binding and signaling.

Main Methods:

• In vitro transfection assays were performed using human and murine cell lines.
• Wild-type (WT) TACI and TACI mutants (C104R and C76R) were expressed and analyzed.
• Ligand binding assays and signaling pathway assessments were conducted.

Main Results:

• The TACI C104R mutant, and its murine counterpart C76R, dominantly interfere with TACI signaling.
• This interference is dependent on the preassociation of mutant TACI with WT TACI in the absence of ligand.
• Mutant TACI proteins do not inhibit ligand binding to WT TACI, suggesting interference with downstream signaling events.

Conclusions:

• The heterozygous C104R TACI mutation leads to CVID through dominant interference with TACI signaling, not haploinsufficiency.
• TACI receptors exist as preassembled oligomeric complexes before ligand binding.
• This study provides a mechanistic understanding of how TACI mutations can impair B cell function and lead to immunodeficiency.